Close

2012 BIO International Convention Opens Voting April 2nd for the Buzz of BIO

Mar 20 2012
Buzz of BIO voting available online.

Registration Open for BIO Livestock Biotech Summit

Mar 15 2012
“With continuous advances in both biomedical and food applications, we look forward to again bringing together the world’s leading industry, academic and government leaders in the fields of science and animal agriculture.”  

BIO’s 9th Annual World Congress Shows Strength of Industrial Biotech and Biofuels in Southeast United States

Mar 15 2012
We are excited to bring this conference to Orlando to highlight the industry's growth, particularly in the Southeast region. 

BIO Announces Richard Lobb as Managing Director of the Council for Biotechnology Information

Mar 14 2012
Lobb will lead CBI’s efforts to communicate science-based information about the benefits and safety of agricultural biotechnology and its contributions to sustainable development.

BIO Hails Senate Passage of PAHPA Reauthorization

Mar 8 2012
The reauthorization of the Pandemic All-Hazards Preparedness Act and the Special Reserve Fund signify the solid commitment of government attention and funding which will allow the biotech industry to do even more to help protect our nation.

BIO Praises House Passage of the Jumpstart Our Business Startups Act

Mar 8 2012
House passes H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act.

BIO Announces Additional Plenary Speakers for the 2012 World Congress to Address Advanced Biofuels, Renewable Chemicals and Creation of a Biobased Economy

Mar 8 2012
We are excited to offer this information-packed plenary program at the 2012 World Congress where speakers will highlight how industrial biotechnology leads to innovation and new jobs while helping to build a biobased economy.

2012 BIO International Convention Super Sessions Focus on Industry Outlook

Mar 7 2012
Global Event for biotechnology to be held June 18-21, 2012 in Boston, MA.

BIO Applauds House Committee Vote to Repeal IPAB

Mar 6 2012
BIO applauded the House Energy and Commerce Committee’s passage of the Medicare Decisions Accountability Act, H.R. 452, which would repeal the Independent Payment Advisory Board (IPAB) established in the health care reform law.

FAST Act Would Provide Patients with Accelerated Access to Innovative Therapies

Mar 6 2012
The FAST Act will modernize the Accelerated Approval pathway to expedite the development of modern, targeted, and personalized therapies for patients suffering from serious and life-threatening diseases, while preserving the Food and Drug Administration's (FDA) robust standards for safety and effectiveness.